In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1905 News Items found
Dr. Geoffrey Ku
FDA Approves Zanidatamab for HER2-Positive Cancers of the Stomach and Esophagus

For patients who are newly diagnosed with gastroesophageal adenocarcinoma, the most common type of stomach and esophageal cancer, the FDA has approved zanidatamab as an additional medication for those who are getting chemotherapy.
MSK Awards and Appointments August 2026
MSK Awards and Appointments August 2026

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Tuomas Tammela Receives 2026 Stephenson Global Schol...
MSK radiation oncologist Nancy Lee
In the Clinic
FDA Reviewing Low-Dose Radiation To Treat HPV Throat Cancer With Fewer Side Effects

Learn how HPV-related head and neck cancer can be treated with a sharply reduced radiation dose to prevent side effects, sometimes without surgery.
Dr. Andrew Kobets
Meet Andrew Kobets, a Pediatric Neurosurgeon at MSK Kids

Andrew Kobets, a pediatric neurosurgeon and member of the MSK Kids team, has a passion for helping children and their families face the challenges of a cancer diagnosis.
Thoracic medical oncologist Dr. Mark Awad
Ask the Expert
New Lung Cancer Treatments Aim To Reduce Deaths and Improve Lives

Learn about the latest advances in lung cancer treatment at MSK.
MSK's Mark Awad, MD, PhD, is seen smiling.
Questions to Ask If You've Been Diagnosed With Lung Cancer

Learn about the questions to ask a lung cancer doctor after being diagnosed, from an MSK specialist who has successfully treated many people for lung cancer.
A person's hand holds a syringe, with its needle inserted into a vial of clear liquid
Reality Check: What You Should Know About Peptides and Cancer

Peptides have become popular with many health and fitness influencers, but experts from MSK say they have concerns about cancer patients using these products because they have not been tested in clinical trials.
MSK thoracic oncologist Kathryn Arbour, MD, seen smiling.
Potential New Treatment for Lung Cancer: Daraxonrasib Aimed at RAS Mutations

A heralded drug that experts hope will open a new era in treating pancreatic cancer is also showing early but strong signs it could be effective agains...
An MSK researcher at work in the lab
MSK Research Highlights August 31, 2026

New MSK research identifies a tumor-secreted protein that primes the lungs for metastasis; shows how a new drug combination improves survival in patients with advanced clear cell renal cell carcinoma; and find a three-drug combination works in most patients newly diagnosed with follicular lymphoma.
Dr. Eileen O'Reilly seen smiling in an exam room.
FDA Approves Daraxonrasib for Pancreatic Cancer: What Patients Need To Know

Learn about a new FDA-approved treatment for pancreatic cancer in which MSK experts played a leading role in opening a new world of treatment options.